Latest News & Features

Reset all filters
Article Type
Channels & Sectors
Geography
Company

Refine Search
Biotechnology
Swedish company’s products treat urologic disorders and colorectal conditions | Portfolio includes unique treatment for prostate cancer radiation therapy.   27 July 2023
article
Judge enters default judgment and permanent injunction order after defendant failed to show in court | Alleged counterfeit medical tools were being sold under Ethicon brand.   27 July 2023
Europe
Interactive statistics chart shows more than 5,000 requests for unitary effect | Data can be filtered by country, language and technology sector.   25 July 2023
Big Pharma
SNIPR Biome has five patents reinstated after court rules they cannot be subject to interference | Rockefeller University had challenged patents on pre-AIA, first-to-invent basis.   20 July 2023
Americas
Polpharma’s injunction bid fails as motion is dismissed with prejudice | Court upholds Swiss Arbitration process.   20 July 2023
Biotechnology
Opposition Division ruling supports the use of immunotherapy patent | Highlights the significance of plausibility in patent evaluation following G 2/21.   18 July 2023
Big Pharma
Delaware court permits counterclaims from Vizgen and Nanostring in separate suits | Firms say patents-in-suit were covered by ‘open and non-exclusive licenses’.   13 July 2023
Big Pharma
Commission says dealmakers ‘knowingly and intentionally’ breached standstill obligation | Grail receives the first-ever fine for a target company under EU merger rules.   13 July 2023
Americas
Precedential decision marks blow for medical device maker after earlier win | PTAB criticised for “fundamental legal error” and “narrow definition”.   11 July 2023
Generics
Decision affects a patent listed in the Orange Book | Generic drug makers have so far failed to secure approval for biosimilar versions of the blockbuster drug.   11 July 2023